Jacob Asset Management of New York’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $13.6K | Hold |
|
|||||
|
2023
Q2 | $29K | Hold |
|
|||||
|
2023
Q1 | $57.9K | Hold |
|
|||||
|
2022
Q4 | $59.6K | Sell |
|
|||||
|
2022
Q3 | $186K | Hold |
|
|||||
|
2022
Q2 | $494K | Buy |
|
|||||
|
2022
Q1 | $802K | Hold |
|
|||||
|
2021
Q4 | $1.2M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Buy |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2021
Q1 | $1.74M | Buy |
|
|||||
|
2020
Q4 | $723K | Buy |
|